These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 36353118

  • 1. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J, Liang Y, Gu JJ, Huang Y, Wang B.
    Front Genet; 2022; 13():991162. PubMed ID: 36353118
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification.
    Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J.
    Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer.
    Huang Z, Lou K, Liu H.
    Front Genet; 2022 Dec 28; 13():1030275. PubMed ID: 36313442
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
    Dai D, Zhuang H, Shu M, Chen L, Long C, Wu H, Chen B.
    Heliyon; 2024 Apr 30; 10(8):e29326. PubMed ID: 38628712
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L, Yang X, Liu J, Wang W, Liu Z, Lin Q, Huang B, Pan J, Mao X.
    Cancer Cell Int; 2023 May 08; 23(1):85. PubMed ID: 37158958
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
    Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S.
    Front Genet; 2022 May 08; 13():906496. PubMed ID: 35938009
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
    Li Y, Zhao K, Wu R, Wang J, Wang Q, Xiong Q, Xie F, Lei H, Feng P.
    J Gastrointest Oncol; 2023 Jun 30; 14(3):1392-1411. PubMed ID: 37435203
    [Abstract] [Full Text] [Related]

  • 14. An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer.
    Li Z, Zhao J, Huang X, Wang J.
    Sci Rep; 2023 Mar 15; 13(1):4302. PubMed ID: 36922569
    [Abstract] [Full Text] [Related]

  • 15. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
    Yang S, Zhou J, Chen Z, Sun Q, Zhang D, Feng Y, Wang X, Sun Y.
    Front Oncol; 2022 Mar 15; 12():934928. PubMed ID: 35992788
    [Abstract] [Full Text] [Related]

  • 16. A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer.
    Xie S, He J, Feng B, Rao D, Wang S, He Y.
    Heliyon; 2023 May 15; 9(5):e15897. PubMed ID: 37215925
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.